Trials / Conditions / NMO Spectrum Disorder (NMOSD)
NMO Spectrum Disorder (NMOSD)
3 registered clinical trials studyying NMO Spectrum Disorder (NMOSD) — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Multiple Sclerosis Versus Neuromyelitis Optica Spectrum Disorder NCT07304960 | Assiut University | — |
| Completed | Efficacy and Safety Study of Satralizumab (SA237) as Monotherapy to Treat Participants With Neuromyelitis Opti NCT02073279 | Hoffmann-La Roche | Phase 3 |
| Completed | Efficacy and Safety Study of Satralizumab (SA237) as Add-on Therapy to Treat Participants With Neuromyelitis O NCT02028884 | Hoffmann-La Roche | Phase 3 |